Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The novel poly(A) polymerase Star-PAP is a signal-regulated switch at the 3'-end of mRNAs.

Li W, Laishram RS, Anderson RA.

Adv Biol Regul. 2013 Jan;53(1):64-76. doi: 10.1016/j.jbior.2012.10.004. Epub 2012 Oct 13. Review.

2.

A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs.

Mellman DL, Gonzales ML, Song C, Barlow CA, Wang P, Kendziorski C, Anderson RA.

Nature. 2008 Feb 21;451(7181):1013-7. doi: 10.1038/nature06666.

PMID:
18288197
3.

Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling.

Li W, Laishram RS, Ji Z, Barlow CA, Tian B, Anderson RA.

Mol Cell. 2012 Jan 13;45(1):25-37. doi: 10.1016/j.molcel.2011.11.017.

4.

Phosphorylation regulates the Star-PAP-PIPKIα interaction and directs specificity toward mRNA targets.

Mohan N, Sudheesh AP, Francis N, Anderson R, Laishram RS.

Nucleic Acids Res. 2015 Aug 18;43(14):7005-20. doi: 10.1093/nar/gkv676. Epub 2015 Jul 2.

5.

CKIalpha is associated with and phosphorylates star-PAP and is also required for expression of select star-PAP target messenger RNAs.

Gonzales ML, Mellman DL, Anderson RA.

J Biol Chem. 2008 May 2;283(18):12665-73. doi: 10.1074/jbc.M800656200. Epub 2008 Feb 27.

6.

CKI isoforms α and ε regulate Star-PAP target messages by controlling Star-PAP poly(A) polymerase activity and phosphoinositide stimulation.

Laishram RS, Barlow CA, Anderson RA.

Nucleic Acids Res. 2011 Oct;39(18):7961-73. doi: 10.1093/nar/gkr549. Epub 2011 Jul 4.

7.

Poly(A) polymerase (PAP) diversity in gene expression--star-PAP vs canonical PAP.

Laishram RS.

FEBS Lett. 2014 Jun 27;588(14):2185-97. doi: 10.1016/j.febslet.2014.05.029. Epub 2014 May 27. Review.

8.

A novel gene expression pathway regulated by nuclear phosphoinositides.

Mellman DL, Anderson RA.

Adv Enzyme Regul. 2009;49(1):11-28. Review. No abstract available.

9.

Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling.

Sun Y, Thapa N, Hedman AC, Anderson RA.

Bioessays. 2013 Jun;35(6):513-22. doi: 10.1002/bies.201200171. Epub 2013 Apr 10. Review.

10.

Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place.

Doughman RL, Firestone AJ, Anderson RA.

J Membr Biol. 2003 Jul 15;194(2):77-89. Review.

PMID:
14502432
11.

CstF-64 and 3'-UTR cis-element determine Star-PAP specificity for target mRNA selection by excluding PAPα.

Kandala DT, Mohan N, A V, A P S, G R, Laishram RS.

Nucleic Acids Res. 2016 Jan 29;44(2):811-23. doi: 10.1093/nar/gkv1074. Epub 2015 Oct 22.

12.
13.

PIP kinases define PI4,5P₂signaling specificity by association with effectors.

Choi S, Thapa N, Tan X, Hedman AC, Anderson RA.

Biochim Biophys Acta. 2015 Jun;1851(6):711-23. doi: 10.1016/j.bbalip.2015.01.009. Epub 2015 Jan 21. Review.

14.

The poly A polymerase Star-PAP controls 3'-end cleavage by promoting CPSF interaction and specificity toward the pre-mRNA.

Laishram RS, Anderson RA.

EMBO J. 2010 Dec 15;29(24):4132-45. doi: 10.1038/emboj.2010.287. Epub 2010 Nov 19.

15.
16.

Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum.

Barlow CA, Laishram RS, Anderson RA.

Trends Cell Biol. 2010 Jan;20(1):25-35. doi: 10.1016/j.tcb.2009.09.009. Epub 2009 Oct 19. Review.

17.

Type I PIPK-alpha regulates directed cell migration by modulating Rac1 plasma membrane targeting and activation.

Chao WT, Daquinag AC, Ashcroft F, Kunz J.

J Cell Biol. 2010 Jul 26;190(2):247-62. doi: 10.1083/jcb.200911110. Erratum in: J Cell Biol. 2010 Aug 9;190(3):479.

18.
19.

The phosphoinositide kinase PIP5K that produces the versatile signaling phospholipid PI4,5P(2).

Kanaho Y, Kobayashi-Nakano A, Yokozeki T.

Biol Pharm Bull. 2007 Sep;30(9):1605-9. Review.

20.

Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I {alpha}.

Sasaki J, Sasaki T, Yamazaki M, Matsuoka K, Taya C, Shitara H, Takasuga S, Nishio M, Mizuno K, Wada T, Miyazaki H, Watanabe H, Iizuka R, Kubo S, Murata S, Chiba T, Maehama T, Hamada K, Kishimoto H, Frohman MA, Tanaka K, Penninger JM, Yonekawa H, Suzuki A, Kanaho Y.

J Exp Med. 2005 Mar 21;201(6):859-70. Epub 2005 Mar 14.

Items per page

Supplemental Content

Write to the Help Desk